AFJK Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Aimei Health Technology Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.60 |
| 52 Week High | US$10.65 |
| 52 Week Low | US$10.15 |
| Beta | 0 |
| 11 Month Change | 0.86% |
| 3 Month Change | 1.53% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFJK | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -0.4% | 0.2% | -1.2% |
| 1Y | n/a | 55.4% | 30.4% |
Return vs Industry: Insufficient data to determine how AFJK performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how AFJK performed against the US Market.
Price Volatility
| AFJK volatility | |
|---|---|
| AFJK Average Weekly Movement | 0.6% |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AFJK has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AFJK's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | n/a | Junheng Xie | n/a |
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd Fundamentals Summary
| AFJK fundamental statistics | |
|---|---|
| Market cap | US$95.68m |
| Earnings (TTM) | US$2.37m |
| Revenue (TTM) | n/a |
40.4x
P/E Ratio0.0x
P/S RatioIs AFJK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFJK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$2.37m |
| Earnings | US$2.37m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did AFJK perform over the long term?
See historical performance and comparison